| Michael Lee Schwalbe, MD | |
|
3600 Providence Dr, Anchorage, AK 99508-4615 | |
| (907) 212-3098 | |
| Not Available |
| Full Name | Michael Lee Schwalbe |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 10 Years |
| Location | 3600 Providence Dr, Anchorage, Alaska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578981650 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 65689 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Alaska Medical Center | Anchorage, AK | Hospital |
| Providence Kodiak Island Medical Ctr | Kodiak, AK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Adl Inc | 5496669491 | 6 |
News Archive
Smokers in recovery from illicit drug use disorders are at greater risk of relapsing three years later compared with those who do not smoke cigarettes. Results of the study by researchers at Columbia University's Mailman School of Public Health and the City University of New York appear online in The Journal of Clinical Psychiatry.
Every 42 seconds someone in the U.S. has a heart attack. Just after noon on March 26, 2016, Julie Kubala, become one of those statistics.
The Pharmaceutical Care Management Association released the following statement on a new report from AARP that found that the price of brand name prescriptions most widely used by Medicare beneficiaries increased by 9.7 percent in the 12 months ending with March 2010 and was much higher than the rate of increase observed during any of the prior eight years
Roche (Basel) and Mirus Bio Corporation (Madison, WI, USA) announced today that they have entered into a definitive agreement under which Roche will acquire Mirus Bio Corporation, a privately-owned US company based in Madison, Wisconsin, that focuses on the discovery and development of innovative nucleic acid based technologies, including a proprietary RNAi (Ribonucleic Acid interference) delivery platform.
A meta-analysis of clinical trials evaluating the effectiveness of aripiprazole for the treatment of Tourette's disorder (TD) in children and adolescents showed a significantly greater overall improvement in total tics and tic severity from pretreatment to post-treatment for the aripiprazole compared to the placebo group.
› Verified 8 days ago
| Entity Name | Adl Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346230984 PECOS PAC ID: 5496669491 Enrollment ID: O20031114000100 |
News Archive
Smokers in recovery from illicit drug use disorders are at greater risk of relapsing three years later compared with those who do not smoke cigarettes. Results of the study by researchers at Columbia University's Mailman School of Public Health and the City University of New York appear online in The Journal of Clinical Psychiatry.
Every 42 seconds someone in the U.S. has a heart attack. Just after noon on March 26, 2016, Julie Kubala, become one of those statistics.
The Pharmaceutical Care Management Association released the following statement on a new report from AARP that found that the price of brand name prescriptions most widely used by Medicare beneficiaries increased by 9.7 percent in the 12 months ending with March 2010 and was much higher than the rate of increase observed during any of the prior eight years
Roche (Basel) and Mirus Bio Corporation (Madison, WI, USA) announced today that they have entered into a definitive agreement under which Roche will acquire Mirus Bio Corporation, a privately-owned US company based in Madison, Wisconsin, that focuses on the discovery and development of innovative nucleic acid based technologies, including a proprietary RNAi (Ribonucleic Acid interference) delivery platform.
A meta-analysis of clinical trials evaluating the effectiveness of aripiprazole for the treatment of Tourette's disorder (TD) in children and adolescents showed a significantly greater overall improvement in total tics and tic severity from pretreatment to post-treatment for the aripiprazole compared to the placebo group.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael Lee Schwalbe, MD 3200 Providence Dr, Anchorage, AK 99508-4615 Ph: (907) 212-3098 | Michael Lee Schwalbe, MD 3600 Providence Dr, Anchorage, AK 99508-4615 Ph: (907) 212-3098 |
News Archive
Smokers in recovery from illicit drug use disorders are at greater risk of relapsing three years later compared with those who do not smoke cigarettes. Results of the study by researchers at Columbia University's Mailman School of Public Health and the City University of New York appear online in The Journal of Clinical Psychiatry.
Every 42 seconds someone in the U.S. has a heart attack. Just after noon on March 26, 2016, Julie Kubala, become one of those statistics.
The Pharmaceutical Care Management Association released the following statement on a new report from AARP that found that the price of brand name prescriptions most widely used by Medicare beneficiaries increased by 9.7 percent in the 12 months ending with March 2010 and was much higher than the rate of increase observed during any of the prior eight years
Roche (Basel) and Mirus Bio Corporation (Madison, WI, USA) announced today that they have entered into a definitive agreement under which Roche will acquire Mirus Bio Corporation, a privately-owned US company based in Madison, Wisconsin, that focuses on the discovery and development of innovative nucleic acid based technologies, including a proprietary RNAi (Ribonucleic Acid interference) delivery platform.
A meta-analysis of clinical trials evaluating the effectiveness of aripiprazole for the treatment of Tourette's disorder (TD) in children and adolescents showed a significantly greater overall improvement in total tics and tic severity from pretreatment to post-treatment for the aripiprazole compared to the placebo group.
› Verified 8 days ago
Dr. Bruce Gentry Ensign, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 4000 Ambassador Dr, Anchorage, AK 99508 Phone: 907-729-1234 Fax: 907-729-1226 | |
Dr. Steven A Jayich, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 2801 Debarr Rd, Department Of Pathology, Anchorage, AK 99508 Phone: 907-264-1171 Fax: 907-264-1702 | |
Lisbeth A Gallagher, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 3200 Providence Dr, Anchorage, AK 99508 Phone: 907-562-2211 Fax: 907-565-8066 | |
Donald Wayne Varner, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 4315 Diplomacy Dr, Anchorage, AK 99508 Phone: 907-563-2662 | |
Dr. Megan C Davies, D.O. Pathology Medicare: Accepting Medicare Assignments Practice Location: 3200 Providence Dr, Pamc Laboratory, Anchorage, AK 99508 Phone: 828-712-2796 | |
James Jay Tiesinga, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 4315 Diplomacy Dr, Attn: Sherry Reedy, Anchorage, AK 99508 Phone: 907-729-3971 Fax: 907-729-1542 | |
Thomas S Mego, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 3200 Providence Dr, Anchorage, AK 99508 Phone: 907-562-2201 |